Logo image of HLMN

HILLMAN SOLUTIONS CORP (HLMN) Stock Fundamental Analysis

USA - NASDAQ:HLMN - US4316361090 - Common Stock

9.66 USD
-0.07 (-0.72%)
Last: 10/22/2025, 10:55:05 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HLMN. HLMN was compared to 130 industry peers in the Machinery industry. Both the profitability and financial health of HLMN have multiple concerns. HLMN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

HLMN had positive earnings in the past year.
In the past year HLMN had a positive cash flow from operations.
In the past 5 years HLMN reported 4 times negative net income.
HLMN had a positive operating cash flow in 4 of the past 5 years.
HLMN Yearly Net Income VS EBIT VS OCF VS FCFHLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of HLMN (0.92%) is worse than 64.62% of its industry peers.
HLMN has a worse Return On Equity (1.80%) than 64.62% of its industry peers.
The Return On Invested Capital of HLMN (2.88%) is worse than 65.38% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HLMN is significantly below the industry average of 10.01%.
The last Return On Invested Capital (2.88%) for HLMN is above the 3 year average (1.94%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.92%
ROE 1.8%
ROIC 2.88%
ROA(3y)-0.11%
ROA(5y)-0.56%
ROE(3y)-0.26%
ROE(5y)-2.17%
ROIC(3y)1.94%
ROIC(5y)1.62%
HLMN Yearly ROA, ROE, ROICHLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

The Profit Margin of HLMN (1.44%) is worse than 63.08% of its industry peers.
Looking at the Operating Margin, with a value of 6.13%, HLMN is doing worse than 60.00% of the companies in the same industry.
In the last couple of years the Operating Margin of HLMN has grown nicely.
The Gross Margin of HLMN (47.80%) is better than 89.23% of its industry peers.
HLMN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.13%
PM (TTM) 1.44%
GM 47.8%
OM growth 3Y102.86%
OM growth 5Y36.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y2.32%
HLMN Yearly Profit, Operating, Gross MarginsHLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HLMN is destroying value.
The number of shares outstanding for HLMN has been increased compared to 1 year ago.
HLMN has more shares outstanding than it did 5 years ago.
HLMN has a better debt/assets ratio than last year.
HLMN Yearly Shares OutstandingHLMN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
HLMN Yearly Total Debt VS Total AssetsHLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 1.83 indicates that HLMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.83, HLMN is not doing good in the industry: 70.77% of the companies in the same industry are doing better.
The Debt to FCF ratio of HLMN is 9.74, which is on the high side as it means it would take HLMN, 9.74 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HLMN (9.74) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.57 indicates that HLMN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.57, HLMN is in line with its industry, outperforming 41.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 9.74
Altman-Z 1.83
ROIC/WACC0.33
WACC8.85%
HLMN Yearly LT Debt VS Equity VS FCFHLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

HLMN has a Current Ratio of 2.28. This indicates that HLMN is financially healthy and has no problem in meeting its short term obligations.
HLMN has a Current ratio (2.28) which is in line with its industry peers.
A Quick Ratio of 0.72 indicates that HLMN may have some problems paying its short term obligations.
HLMN has a worse Quick ratio (0.72) than 83.85% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 0.72
HLMN Yearly Current Assets VS Current LiabilitesHLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

HLMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.77%, which is quite good.
The Revenue has been growing slightly by 1.93% in the past year.
The Revenue has been growing slightly by 3.93% on average over the past years.
EPS 1Y (TTM)12.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.25%
Revenue 1Y (TTM)1.93%
Revenue growth 3Y1.08%
Revenue growth 5Y3.93%
Sales Q2Q%6.16%

3.2 Future

The Earnings Per Share is expected to grow by 16.84% on average over the next years. This is quite good.
Based on estimates for the next years, HLMN will show a small growth in Revenue. The Revenue will grow by 5.08% on average per year.
EPS Next Y13.27%
EPS Next 2Y8.98%
EPS Next 3Y11.15%
EPS Next 5Y16.84%
Revenue Next Year5.85%
Revenue Next 2Y6.85%
Revenue Next 3Y5.98%
Revenue Next 5Y5.08%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HLMN Yearly Revenue VS EstimatesHLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
HLMN Yearly EPS VS EstimatesHLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.23 indicates a rather expensive valuation of HLMN.
Based on the Price/Earnings ratio, HLMN is valued a bit cheaper than 70.77% of the companies in the same industry.
HLMN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.77, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.64 indicates a correct valuation of HLMN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HLMN indicates a somewhat cheap valuation: HLMN is cheaper than 72.31% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.23, HLMN is valued a bit cheaper.
Industry RankSector Rank
PE 18.23
Fwd PE 15.64
HLMN Price Earnings VS Forward Price EarningsHLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HLMN is valued a bit cheaper than the industry average as 73.85% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLMN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 26.67
EV/EBITDA 11.29
HLMN Per share dataHLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.37
PEG (5Y)N/A
EPS Next 2Y8.98%
EPS Next 3Y11.15%

0

5. Dividend

5.1 Amount

HLMN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HILLMAN SOLUTIONS CORP

NASDAQ:HLMN (10/22/2025, 10:55:05 AM)

9.66

-0.07 (-0.72%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners104.73%
Inst Owner Change-0.76%
Ins Owners1.13%
Ins Owner Change2.81%
Market Cap1.91B
Revenue(TTM)1.51B
Net Income(TTM)21.73M
Analysts81.43
Price Target12.56 (30.02%)
Short Float %2.93%
Short Ratio4.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.57%
Min EPS beat(2)1.2%
Max EPS beat(2)15.94%
EPS beat(4)2
Avg EPS beat(4)1.89%
Min EPS beat(4)-7.7%
Max EPS beat(4)15.94%
EPS beat(8)5
Avg EPS beat(8)5.14%
EPS beat(12)9
Avg EPS beat(12)33.05%
EPS beat(16)12
Avg EPS beat(16)285.05%
Revenue beat(2)1
Avg Revenue beat(2)0.1%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)1.61%
Revenue beat(4)1
Avg Revenue beat(4)-0.63%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)1.61%
Revenue beat(8)1
Avg Revenue beat(8)-1.53%
Revenue beat(12)1
Avg Revenue beat(12)-2.32%
Revenue beat(16)2
Avg Revenue beat(16)-1.92%
PT rev (1m)0%
PT rev (3m)16.57%
EPS NQ rev (1m)0.7%
EPS NQ rev (3m)-13.68%
EPS NY rev (1m)0.82%
EPS NY rev (3m)4.75%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)1.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE 18.23
Fwd PE 15.64
P/S 1.27
P/FCF 26.67
P/OCF 12.32
P/B 1.58
P/tB N/A
EV/EBITDA 11.29
EPS(TTM)0.53
EY5.49%
EPS(NY)0.62
Fwd EY6.39%
FCF(TTM)0.36
FCFY3.75%
OCF(TTM)0.78
OCFY8.11%
SpS7.61
BVpS6.11
TBVpS-1.01
PEG (NY)1.37
PEG (5Y)N/A
Graham Number8.53
Profitability
Industry RankSector Rank
ROA 0.92%
ROE 1.8%
ROCE 4.43%
ROIC 2.88%
ROICexc 2.93%
ROICexgc 9.33%
OM 6.13%
PM (TTM) 1.44%
GM 47.8%
FCFM 4.76%
ROA(3y)-0.11%
ROA(5y)-0.56%
ROE(3y)-0.26%
ROE(5y)-2.17%
ROIC(3y)1.94%
ROIC(5y)1.62%
ROICexc(3y)1.97%
ROICexc(5y)1.64%
ROICexgc(3y)6.76%
ROICexgc(5y)6%
ROCE(3y)2.98%
ROCE(5y)2.49%
ROICexgc growth 3Y110.94%
ROICexgc growth 5Y37.21%
ROICexc growth 3Y112.78%
ROICexc growth 5Y43.98%
OM growth 3Y102.86%
OM growth 5Y36.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y2.32%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 9.74
Debt/EBITDA 2.98
Cap/Depr 60.9%
Cap/Sales 5.54%
Interest Coverage 1.88
Cash Conversion 67.63%
Profit Quality 329.53%
Current Ratio 2.28
Quick Ratio 0.72
Altman-Z 1.83
F-Score7
WACC8.85%
ROIC/WACC0.33
Cap/Depr(3y)59.2%
Cap/Depr(5y)51.21%
Cap/Sales(3y)4.97%
Cap/Sales(5y)4.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.25%
EPS Next Y13.27%
EPS Next 2Y8.98%
EPS Next 3Y11.15%
EPS Next 5Y16.84%
Revenue 1Y (TTM)1.93%
Revenue growth 3Y1.08%
Revenue growth 5Y3.93%
Sales Q2Q%6.16%
Revenue Next Year5.85%
Revenue Next 2Y6.85%
Revenue Next 3Y5.98%
Revenue Next 5Y5.08%
EBIT growth 1Y6.16%
EBIT growth 3Y105.05%
EBIT growth 5Y41.6%
EBIT Next Year157.66%
EBIT Next 3Y43.13%
EBIT Next 5Y28.33%
FCF growth 1Y-49.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.36%
OCF growth 3YN/A
OCF growth 5Y28.46%